Associate Professor

Lisa Kaminskas

Email: 
Phone: 
+61 7 336 53124

Availability

Associate Professor Lisa Kaminskas is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, University of Adelaide

Search Professor Lisa Kaminskas’s works on UQ eSpace

97 works between 2000 and 2024
All (97) Journal Article (92) Book Chapter (3) Conference Publication (2)

61 - 80 of 97 works

2014

Journal Article

Practical lessons in murine thoracic lymph duct cannulations: Observations in female and male mice across four different strains that impact on cannulatability

Caliph, Suzanne M., Shackleford, David M., Ascher, David B. and Kaminskas, Lisa M. (2014). Practical lessons in murine thoracic lymph duct cannulations: Observations in female and male mice across four different strains that impact on cannulatability. Journal of Pharmaceutical Sciences, 104 (3), 1207-1209. doi: 10.1002/jps.24312

Practical lessons in murine thoracic lymph duct cannulations: Observations in female and male mice across four different strains that impact on cannulatability

2014

Journal Article

Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers

Ryan, Gemma M., Kaminskas, Lisa M. and Porter, Christopher J.H. (2014). Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. Journal of Controlled Release, 193, 241-256. doi: 10.1016/j.jconrel.2014.04.051

Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers

2014

Journal Article

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Kaminskas, Lisa M., McLeod, Victoria M., Ryan, Gemma M., Kelly, Brian D., Haynes, John M., Williamson, Mark, Thienthong, Neeranat, Owen, David J. and Porter, Christopher J. H. (2014). Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. Journal of Controlled Release, 183 (1), 18-26. doi: 10.1016/j.jconrel.2014.03.012

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

2014

Journal Article

The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats

Dahlberg, Annette M., Kaminskas, Lisa M., Smith, Alanna, Nicolazzo, Joseph A., Porter, Christopher J. H., Bulitta, Jürgen B. and McIntosh, Michelle P. (2014). The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats. Molecular Pharmaceutics, 11 (2), 496-504. doi: 10.1021/mp400464s

The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats

2013

Journal Article

PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin

Ryan, Gemma M., Kaminskas, Lisa M., Bulitta, Juergen B., McIntosh, Michelle P., Owen, David J. and Porter, Christopher J. H. (2013). PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin. Journal of Controlled Release, 172 (1), 128-136. doi: 10.1016/j.jconrel.2013.08.004

PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin

2013

Journal Article

Designing a multicomponent spray-dried formulation platform for pulmonary delivery of biomacromolecules: the effect of polymers on the formation of an amorphous matrix for glassy state stabilization of biomacromolecules

Sou, Tomás, McIntosh, Michelle P., Kaminskas, Lisa M., Prankerd, Richard J. and Morton, David A. V. (2013). Designing a multicomponent spray-dried formulation platform for pulmonary delivery of biomacromolecules: the effect of polymers on the formation of an amorphous matrix for glassy state stabilization of biomacromolecules. Drying Technology, 31 (13-14), 1451-1458. doi: 10.1080/07373937.2013.788019

Designing a multicomponent spray-dried formulation platform for pulmonary delivery of biomacromolecules: the effect of polymers on the formation of an amorphous matrix for glassy state stabilization of biomacromolecules

2013

Journal Article

Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent

Ryan, Gemma M., Kaminskas, Lisa M., Kelly, Brian D., Owen, David J., McIntosh, Michelle P. and Porter, Christopher J. H. (2013). Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent. Molecular Pharmaceutics, 10 (8), 2986-2995. doi: 10.1021/mp400091n

Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent

2013

Journal Article

Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae

Velkov, Tony, Deris, Zakuan Z., Huang, Johnny X., Azad, Mohammad A. K., Butler, Mark, Sivanesan, Sivashangarie, Kiminskas, Lisa M., Dong, Yao-Da, Boyd, Ben, Baker, Mark A., Cooper, Matthew A., Nation, Roger L. and Li, Jian (2013). Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Innate Immunity, 20 (4), 350-363. doi: 10.1177/1753425913493337

Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae

2013

Journal Article

PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases

Kaminskas, Lisa M., Ascher, David B., McLeod, Victoria M., Herold, Marco J., Le, Caroline P., Sloan, Erica K. and Porter, Christopher J. H. (2013). PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases. Journal of Controlled Release, 168 (2), 200-208. doi: 10.1016/j.jconrel.2013.03.006

PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases

2013

Journal Article

The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules

Sou, Tomás, Kaminskas, Lisa M., Nguyen, Tri-Hung, Carlberg, Renée, McIntosh, Michelle P. and Morton, David A.V. (2013). The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. European Journal of Pharmaceutics and Biopharmaceutics, 83 (2), 234-243. doi: 10.1016/j.ejpb.2012.10.015

The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules

2012

Journal Article

Chaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stress

Burcham, Philip C., Raso, Albert and Kaminskas, Lisa M. (2012). Chaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stress. Molecular Pharmacology, 82 (5), 876-886. doi: 10.1124/mol.112.078956

Chaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stress

2012

Journal Article

Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation

Kaminskas, Lisa M., McLeod, Victoria M., Porter, Christopher J. H. and Boyd, Ben J. (2012). Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation. Molecular Pharmaceutics, 9 (3), 355-373. doi: 10.1021/mp2005966

Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation

2012

Journal Article

Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models

Kaminskas, Lisa M., McLeod, Victoria M., Kelly, Brian D., Cullinane, Carleen, Sberna, Gian, Williamson, Mark, Boyd, Ben J., Owen, David J. and Porter, Christopher J. H. (2012). Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models. Molecular Pharmaceutics, 9 (3), 422-432. doi: 10.1021/mp200522d

Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models

2012

Journal Article

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

Kaminskas, Lisa M., McLeod, Victoria M., Kelly, Brian D., Sberna, Gian, Boyd, Ben J., Williamson, Mark, Owen, David J. and Porter, Christopher J. H. (2012). A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine, 8 (1), 103-111. doi: 10.1016/j.nano.2011.05.013

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

2012

Journal Article

Erratum: Dendrimer pharmacokinetics: The effect of size, structure and surface characteristics on ADME properties (Nanomedicine (2011) 6:6 (1063-1084))

Kaminskas, Lisa M., Boyd, Ben J. and Porter, Christopher J.H. (2012). Erratum: Dendrimer pharmacokinetics: The effect of size, structure and surface characteristics on ADME properties (Nanomedicine (2011) 6:6 (1063-1084)). Nanomedicine, 7 (1). doi: 10.2217/nnm.11.173

Erratum: Dendrimer pharmacokinetics: The effect of size, structure and surface characteristics on ADME properties (Nanomedicine (2011) 6:6 (1063-1084))

2011

Journal Article

Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: a design of experiment approach

Sou, Tomas, Orlando, Laurence, McIntosh, Michelle P., Kaminskas, Lisa M. and Morton, David A. V. (2011). Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: a design of experiment approach. International Journal of Pharmaceutics, 421 (2), 220-229. doi: 10.1016/j.ijpharm.2011.09.018

Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: a design of experiment approach

2011

Journal Article

Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance

Kaminskas, Lisa M., Mcleod, Victoria M., Porter, Christopher J. H. and Boyd, Ben J. (2011). Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance. Journal of Pharmaceutical Sciences, 100 (11), 5069-5077. doi: 10.1002/jps.22682

Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance

2011

Journal Article

Targeting the lymphatics using dendritic polymers (dendrimers)

Kaminskas, Lisa M. and Porter, Christopher J. H. (2011). Targeting the lymphatics using dendritic polymers (dendrimers). Advanced Drug Delivery Reviews, 63 (10-11), 890-900. doi: 10.1016/j.addr.2011.05.016

Targeting the lymphatics using dendritic polymers (dendrimers)

2011

Journal Article

Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties

Kaminskas, Lisa M., Boyd, Ben J. and Porter, Christopher J. H. (2011). Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. Nanomedicine, 6 (6), 1063-1084. doi: 10.2217/nnm.11.67

Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties

2011

Journal Article

Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker

Kaminskas, Lisa M., Kelly, Brian D., McLeod, Victoria M., Sberna, Gian, Owen, David J., Boyd, Ben J. and Porter, Christopher J. H. (2011). Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. Journal of Controlled Release, 152 (2), 241-248. doi: 10.1016/j.jconrel.2011.02.005

Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker

Current funding

  • 2024 - 2028
    Nanoparticle gene therapy for cystic fibrosis
    NHMRC MRFF PPHR - Chronic Respiratory Conditions
    Open grant

Past funding

  • 2020 - 2021
    UQ AWARE - Dr Lisa Kaminskas
    UQ Amplify Women's Academic Research Equity
    Open grant
  • 2019 - 2021
    A/Prof Lisa Kaminskas - AQ WRAP
    Advance Queensland Women's Research Assistance Program
    Open grant
  • 2019 - 2023
    Understanding the kinetics of nanomedicine clearance from healthy and diseased lungs
    NHMRC Project Grant
    Open grant
  • 2019
    Advanced Brightfield and Fluorescent High Speed and Throughput Slide Scanner for biological, medical, materials science, and agricultural applications
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2017 - 2018
    Investigation of the Pharmacokinetics of Avalyn Pharma's Compound in Sheep
    UniQuest Pty Ltd
    Open grant
  • 2017 - 2018
    A Pharmacology Screening Facility to Accelerate Drug Discovery and Development
    UQ Major Equipment and Infrastructure
    Open grant
  • 2017 - 2019
    Designing Nanoparticles to Combat Cellular Dysfunction (ARC Discovery Grant administered by Monash University)
    Monash University
    Open grant
  • 2016 - 2020
    Improving cancer survival by optimising drug exposure at sites of cancer metastasis
    NHMRC Career Development Fellowship
    Open grant
  • 2016
    Optimising the therapeutic efficacy of protein-based drugs against lymph-resident diseases.
    NHMRC Project Grant
    Open grant

Availability

Associate Professor Lisa Kaminskas is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Associate Professor Lisa Kaminskas directly for media enquiries about:

  • cancer drug delivery
  • lung drug delivery
  • lymphatic system drug delivery
  • nanomedicine

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au